SecBot SecBot
6-K ·Filed Aug 14, 2026

BAK

BRASKEM SA
MIXED
Impact 6/10
Horizonweeks Processed2mo ago SEC0001292814-26-004258
Actionable Insight ◆ Mixed

The Q2 EBITDA beat is a tactical spike from a supply shock, not a sustainable turnaround. The base case for 2H26/2027 points to spread normalization, and the company faces a massive Alagoas liability and a going-concern warning. Traders should view this as a potential short-term rally to sell into, given the structural overcapacity and liquidity risks. Monitor for any capital structure announcements regarding Braskem Idesa.

DirectionMixed
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
BAK ▲ +3.08% at T+20d
NEUTRAL call +3.08% · α vs SPY +5.07% · entry $1.95 → $2.01
Next anchor: T+60d in 14d
Latest observation: T+49 +84.68% FF3 residual α
Entry = T+0 close
Aug 14, 2026
via day close
T+1d
+3.08%
call +3.08% · α +3.55%
$2.01
settled 2mo ago
T+5d
+2.05%
call +2.05% · α +3.42%
$1.99
settled 2mo ago
T+20d
+3.08%
call +3.08% · α +5.07%
$2.01
settled 6w ago
T+60d
Pending
in 14d

Price Chart

Loading chart...

Executive Summary

Braskem reported Q2 2026 consolidated recurring EBITDA of US$1,043 million, a dramatic improvement from US$192 million in Q1 2026 and US$74 million in Q2 2025, driven by a supply shock from Middle East disruptions that temporarily widened petrochemical spreads. However, the company explicitly frames this as a tactical, non-structural event, and the base scenario for 2H26/2027 points to normalization of spreads. The company remains under substantial doubt as a going concern per its April 20-F, with a massive R$18.2 billion Alagoas provision and ongoing liquidity preservation measures, including at Braskem Idesa.

Key Facts

  • Consolidated recurring EBITDA of US$1,043 million in Q2 2026, up from US$192 million in Q1 2026 and US$74 million in Q2 2025.
  • EBITDA margin improved to 24.2% in Q2 2026 from 6.5% in Q1 2026 and 2.3% in Q2 2025.
  • The company states the 2Q26 scenario is a 'tactical value capture opportunity' and not a structural change, with spreads expected to normalize in 2H26/2027.
  • The global petrochemical industry remains in a downcycle with overcapacity, particularly in Asia.
  • Alagoas provision totals R$18.2 billion, with R$14.6 billion already disbursed; net provision balance decreased to approximately R$3.2 billion at end of Q2 2026 from R$3.4 billion at end of Q1 2026.
  • Priorities for 2H26 include optimizing capital structure, including Braskem Idesa, and balancing the capital structure to sustain the company over the long term.
  • The 20-F filed in April 2026 confirmed substantial doubt about the company's ability to continue as a going concern.

Financial Impact

Consolidated recurring EBITDA surged to US$1,043 million in Q2 2026, a 443% increase from Q1 2026. However, the company's 20-F confirmed substantial doubt about going concern, and the Alagoas provision remains at R$18.2 billion.

recurring_ebitdaebitda_marginliquiditygoing_concern

Risk Factors

  • Normalization of petrochemical spreads in 2H26/2027, reversing Q2 gains.
  • Going-concern risk confirmed in the April 20-F, with R$18.2 billion in Alagoas liabilities.
  • Liquidity preservation measures at Braskem Idesa impacting Mexico segment operations.
  • Global petrochemical overcapacity, particularly in Asia, continues to pressure the industry.

Market Snapshot

Exchange
NYSE
Sector
Industrial Organic Chemicals
Analyst Consensus
7% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (BAK) — Batch item 10001292814-26-004258
Document: 0001292814-26-004258-index-headers.html0001292814-26-004258
Document: 0001292814-26-004258-index.html0001292814-26-004258
Document: 0001292814-26-004258.txt0001292814-26-004258
6-K Filing (BAK) — Batch item 50001292814-26-004258
53 reports for BAK
Performance horizon
83% Hit rate @ T+60 5 of 6 directional calls Went positive at some point 16 of 20 best @ T+60▲ +55.04%May 14, 2026
Filters
Rows
Reports for BAK — sortable, filterable
TypeNow
Oct 26, 2026
today
6-K
BEARISH ★ 6/10
$1.12awaiting T+60—$1.10 (+1.79%)
Oct 21, 2026
4d ago
6-K
NEUTRAL ★ 3/10
$1.60awaiting T+60—$1.10 (−31.25%)
Oct 21, 2026
4d ago
6-K
BEARISH ★ 7/10
$1.60awaiting T+60—$1.10 (+31.25%)
Oct 9, 2026
16d ago
6-K
NEUTRAL ★ 2/10
$1.78awaiting T+60—$1.10 (−38.20%)
Oct 9, 2026
16d ago
6-K
NEUTRAL ★ 2/10
$1.78awaiting T+60—$1.10 (−38.20%)
Sep 25, 2026
4w ago
6-K
BEARISH ★ 7/10
$1.49awaiting T+60—$1.10 (+26.17%)
Sep 25, 2026
4w ago
6-K
BEARISH ★ 7/10
$1.54awaiting T+60—$1.10 (+28.57%)
Aug 28, 2026
8w ago
6-K
BEARISH ★ 8/10
$1.68awaiting T+60—$1.10 (+34.52%)
Aug 26, 2026
8w ago
6-K
BEARISH ★ 6/10
$1.64awaiting T+60—$1.10 (+32.93%)
Aug 25, 2026
8w ago
6-K
BEARISH ★ 8/10
$1.48awaiting T+60—$1.10 (+25.68%)
Showing 10 of 53

US Market Status

Market Closed — Opens Tue (16h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 14, 2026